Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor
1 clinical trials · Condition
◉ Watch Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor
| Record | Firm | Date |
|---|---|---|
| Gemcitabine Hydrochloride With or Without WEE1 Inhibitor MK-1775 in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer (NCT02101775) | National Cancer Institute (NCI) | 2014-07-21 |
Track Ovarian Malignant Mixed Mesodermal (Mullerian) Tumor automatically
Every clearance here is in the API, with alerts when new ones post.